3 YEARS IN, PROGRAM BUILDS ON CAPABILITY AND CONNECTIVITY FOR EARLY CAREER RESEARCHERS IN ENT MEDICAL DEVICES Beyond Science gives in theatre opportunities, networking with stakeholders and support from mentors
With
Professor Payal Mukherjee, Adult and Paediatric ENT Surgeon
Otologist, Cochlear Implant and Skull Base Surgeon &
Clinical Professor, Macquarie University &
TGA Advisory Committee for Medical Devices &
Clinical Associate Professor, University of Sydney &
Surgical Innovation Lead, RPA Institute of Academic Surgery &
Head of Department ENT, Sydney Adventist Hospital &
Co-Founder & Co-Director, Beyond Science
Distinguished Professor Gordon Wallace AO,
Director, Intelligent Polymer Research Institute,
University of Wollongong &
Co-Founder & Co-Director, Beyond Science
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Sydney & Wollongong | August 2025
Surgeon-scientists and surgeon-innovators have an important role in the entire medical technology translational cycle; not only from discovery to commercialisation, but in ensuring that health technologies are implemented in value-based manner.
This includes defining safety and regulatory standards, balancing patient outcomes against health care costs, and working with policy makers to ensure that funding is both sustainable and promotes equitable access to technology.
Despite a rich history of biomedical innovation in Australia, there are limited training opportunities for surgeons to develop these skills. Within NSW, there are no formal surgeon-scientist training pathways in Otolaryngology, Head and Neck Surgery.
In 2022, Distinguished Professor Gordon Wallace AO and Professor Mukherjee jointly established Beyond Science as a clinician led, academically supported and clinician run Australian-first medical technology translation program.
The program is aimed at early career researchers and clinician-scientists working in medical device research specifically in otolaryngology (ear, nose, and throat), head and neck surgery.
Its core mission is to build capability and foster connections between researchers and key stakeholders such as industry, government, universities, and health systems.
This is through helping researchers understand health system priorities and translation pathways from research to real-world impact. Uniquely, this includes opportunity to enter surgical environments for observation and tissue collection.
Australian Health Journal spoke to its founders about how it supports academic mentorship and creates networking opportunities to help early career stage medical device researchers connect with clinicians, policymakers, industry leaders, and funding bodies.
Beyond Science is funded by Passe & Williams Foundation & the Sydney Local Health District
Source: Adapted from Beyond Science, RACS and University of Wollongong websites
You Might also like
-
Challenge advances health technologies and medical devices in the MedTech sector
Australia’s clinical trials community came together to celebrate outstanding research and recognise the people and teams making a meaningful difference to healthcare at the 2026 ACTA Trial of the Year Awards.
Now in its 10th year, the awards continue to shine a light on investigator-led clinical trials and initiatives that are improving clinical practice, influencing healthcare policy and delivering better outcomes for patients across Australia and beyond.
-
Getting the conversation going on the connection between oral health and chronic conditions
Dr. Carol Tran is an Oral Health Therapist and co-founder of Oral Health Home, an organisation focused on innovative, prevention-oriented oral health education and outreach. She is a Past President of Dental Hygienists Association of Australia (DHAA) and currently is the Scientific Program Chair, for upcoming congress in October 2025, for the newly formed Oral Health Association of Australia (OHAA).
-
ICTD: Clinical trials in regional, rural and remote Australia
To mark International Clinical Trials Day 2026, Australian Health Journal commences a 4 part special series leaving up to 20th May. Through conversations with leading researchers, clinicians and trial organisations, the series highlights achievements in the year that was for clinical trials. The first segment is an example of how in-person clinical trial access has improved for regional, rural and remote communities.